Continuing my World Antimicrobial Resistance (AMR) Awareness Week series, let’s talk about antimicrobial prophylaxis in animals.
If you asked random people on the street “Should antibiotics be given to healthy animals?” I’d expect the answer to be a resounding no. But, as with most things related to AMR, the answer is not as
This is a question I get a lot. My typical answer is “yes, but…”
The “but” can lead to a long discussion. I have a bit of a complex relationship with antimicrobial use (AMU) targets.
As we start World Antimicrobial Resistance (AMR) Awareness Week (WAAW) 2023, I’ll cover a variety of areas about this important topic.
Why do we even care about AMR?
AMR is an urgent international problem. It threatens the healthcare (human and animal) gains that we’ve made over the past century. It’s estimated that AMR was
Dog gets diarrhea, then dog gets metronidazole (or another antimicrobial).
That’s a pretty rote approach to diarrhea in many areas, and one we’ve been battling for years, because there’s no evidence that antibiotics help dogs in these cases (and increasing evidence that they might even hurt).
Trying to get veterinarians NOT to prescribe antimicrobials in
I had an interesting discussion yesterday about the “antimicrobial pipeline” as part of the Global Leaders Group on Antimicrobial Resistance. When we talk about the antimicrobial pipeline, we’re referring to the dwindling number of new antimicrobial drugs that are currently in development. Antimicrobial research and development (R&D) has fallen by the wayside over the
My own animals provide frequent fodder for this blog, both good and bad. Rumple’s been featured a few times before, and his latest escapade is a great antimicrobial stewardship case.
Rumple’s an indoor-outdoor cat that we adopted years ago through Guelph Humane Society’s working cat program. He was deemed unsuitable for a household, so we
An abstract in the upcoming European Conference on Clinical Microbiology and Infectious Diseases (ECCMID) has gotten a fair bit of press and led to a lot of questions because of some sensational headlines. I’ll hopefully be able to check out all the details at ECCMID (I’ll be there for the Global Leaders Group on AMR
Being asked to coordinate a paper for the Journal of Law, Medicine & Ethics wasn’t on my academic bingo card for the year, but like a lot of things in recent years, I’ve come to expect the unexpected. The paper in question is part of a special edition entitled Addressing Antimicrobial Resistance through the Proposed
The antibiotic development pipeline is drying up. More companies are abandoning the area because antibiotics are expensive to develop and license, but they are low profit drugs that we try to use as little as possible.
This is a big issue for human medicine, and was the focus of a lot of discussion at this
I’ve written (ranted?) about this before – namely the misuse of antimicrobials intended for treatment of aquarium fish in other species. Usually such posts are followed by a deluge of nasty emails along with a bunch of curious requests for links to fish antibiotic sellers (8% kickback available!).
Another sponsorship request came in this morning
